12,080.85-45.05
Stock Analysis, IPO, Mutual Funds, Bonds & More

Strides Pharma Q1 net loss at Rs 4 crore

Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review.

PTI|
Last Updated: Aug 08, 2018, 02.12 PM IST
0Comments
ThinkStock Photos
Fall-and-decline---TS
The company had posted a net profit of Rs 5.78 crore in April-June 2017, Strides Pharma said in a BSE filing.
Strides Pharma Science today reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30. The company had posted a net profit of Rs 5.78 crore in April-June 2017, Strides Pharma said in a BSE filing.

Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review. It was Rs 657.78 crore for the same period a year ago.

Shares of the company were trading at Rs 416.40 per scrip on BSE, up 6.20 per cent from the previous close.

Also Read

Oyo loss widens to $335 million

IDBI up for sale loss, stock and bank

Terms set for DHFL liquidation after big loss

Payment companies weigh ways to recoup MDR losses

Tata Steel 'can't keep funding losses' at UK's loss-making Port Talbot plant: N Chandrasekaran

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service